Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
10:51am, Monday, 06'th May 2024
Viatris' (VTRS) Q1 results are likely to gain from momentum in its branded and incremental revenues from new product launches.
Viatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:21am, Monday, 06'th May 2024
Evaluate the expected performance of Viatris (VTRS) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics fo
Viatris to Participate in the BofA Securities 2024 Health Care Conference
05:00pm, Thursday, 02'nd May 2024
PITTSBURGH , May 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the BofA Securities 2024 Health Care Conference at t
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Thursday, 02'nd May 2024
Viatris (VTRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health
06:59am, Wednesday, 01'st May 2024
PITTSBURGH and LONDON , May 1, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, recently launched Unmind as part of its global wellbeing program, Elevate. Unmind is a l
Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.
06:28pm, Wednesday, 24'th Apr 2024
The Inflation Reduction Act has reduced the exclusivity period for small-molecule drugs, potentially leading to earlier market entry for generic drugs. The shortened exclusivity period may create a bu
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
12:16pm, Thursday, 18'th Apr 2024
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, TEVA and VTRS.
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
04:30pm, Tuesday, 16'th Apr 2024
PITTSBURGH , April 16, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets.
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
08:00am, Monday, 15'th Apr 2024
PITTSBURGH , April 15, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will b
Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential
05:01pm, Monday, 08'th Apr 2024
Viatris Inc. is a deep value pharmaceutical company with a low valuation and a 4.1% yield. Viatris has seen a slowdown in top line decline and has a promising pipeline of potential blockbuster drugs.
UK watchdog says Theramex-Viatris deal raises competition concerns
06:26am, Thursday, 04'th Apr 2024
Britain's competition watchdog said Theramex's purchase of European rights to two of Viatris' women's healthcare products ranges could lead to higher prices and lesser options for hormone replacement
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
11:53am, Monday, 01'st Apr 2024
Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance to
Viatris Stock Is Still Worth Buying
01:59am, Saturday, 30'th Mar 2024
Viatris Inc. stock has risen by 26.7% since my November 2023 bullish call, outperforming the S&P 500 Index. It's time to update my thesis - read on. Although net sales declined (as did EBITDA and net
Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?
12:36pm, Friday, 29'th Mar 2024
Viatris (VTRS) reported earnings 30 days ago. What's next for the stock?
Viatris Inc. (VTRS) R&D Event (Transcript)
03:26pm, Wednesday, 27'th Mar 2024
Viatris Inc. (VTRS) R&D Event (Transcript)
